Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes

OBJECTIVE We aimed to determine the corneal confocal microscopy (CCM) parameter that best identifies diabetic sensorimotor polyneuropathy (DSP) in type 1 diabetes and to describe its performance characteristics. RESEARCH DESIGN AND METHODS Concurrent with clinical and electrophysiological examination for classification of DSP, CCM was performed on 89 type 1 diabetic and 64 healthy subjects to determine corneal nerve fiber length (CNFL), density, tortuosity, and branch density. Area under the curve (AUC) and optimal thresholds for DSP identification in those with diabetes were determined by receiver operating characteristic (ROC) curve analysis. RESULTS DSP was present in 33 (37%) subjects. With the exception of tortuosity, CCM parameters were significantly lower in DSP case subjects. In ROC curve analysis, AUC was greatest for CNFL (0.88) compared with fiber density (0.84, P = 0.0001), branch density (0.73, P < 0.0001), and tortuosity (0.55, P < 0.0001). The threshold value that optimized sensitivity and specificity for ruling in DSP was a CNFL of ≤14.0 mm/mm2 (sensitivity 85%, specificity 84%), associated with positive and negative likelihood ratios of 5.3 and 0.18. An alternate approach that used separate threshold values maximized sensitivity (threshold value ≥15.8 mm/mm2, sensitivity 91%, negative likelihood ratio 0.16) and specificity (≤11.5 mm/mm2, specificity 93%, positive likelihood ratio 8.5). CONCLUSIONS Among CCM parameters, CNFL best discriminated DSP cases from control subjects. A single threshold offers clinically acceptable operating characteristics, although a strategy that uses separate thresholds to respectively rule in and rule out DSP has excellent performance while minimizing unclassified subjects. We hypothesize that values between these thresholds indicate incipient nerve injury that represents those individuals at future neuropathy risk.

[1]  M. A. Dabbah,et al.  Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging , 2011, Medical Image Anal..

[2]  A. Orszag,et al.  Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[3]  A. Orszag,et al.  How sensitive is the case definition for diabetic sensorimotor polyneuropathy to the use of different symptoms, signs, and nerve conduction parameters in type 1 diabetes? , 2011, Diabetes research and clinical practice.

[4]  Mitra Tavakoli,et al.  Corneal confocal microscopy: a novel non-invasive technique to quantify small fibre pathology in peripheral neuropathies. , 2011, Journal of visualized experiments : JoVE.

[5]  N. Pritchard,et al.  Corneal Sensitivity as an Ophthalmic Marker of Diabetic Neuropathy , 2010, Optometry and vision science : official publication of the American Academy of Optometry.

[6]  M. A. Dabbah,et al.  Dual-Model Automatic Detection of Nerve-Fibres in Corneal Confocal Microscopy Images , 2010, MICCAI.

[7]  J. Graham,et al.  Repeatability of Measuring Corneal Subbasal Nerve Fiber Length in Individuals With Type 2 Diabetes , 2010, Eye & contact lens.

[8]  Anselm Kampik,et al.  In vivo confocal microscopy of corneal small fiber damage in diabetes mellitus , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[9]  Philip B. Morgan,et al.  A novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy , 2010 .

[10]  A. Orszag,et al.  Prediction of Incident Diabetic Neuropathy Using the Monofilament Examination , 2010, Diabetes Care.

[11]  R. Dworkin,et al.  Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs. , 2009, The journal of pain : official journal of the American Pain Society.

[12]  J. Lupski,et al.  Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review) , 2009, Neurology.

[13]  J. Lupski,et al.  Practice Parameter: The Evaluation of Distal Symmetric Polyneuropathy: The Role of Autonomic Testing, Nerve Biopsy, and Skin Biopsy (An Evidence‐Based Review) , 2009, PM & R : the journal of injury, function, and rehabilitation.

[14]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[15]  J. Singleton,et al.  Impaired Glucose Tolerance and Neuropathy , 2008, The neurologist.

[16]  Nathan Efron,et al.  Surrogate Markers of Small Fiber Damage in Human Diabetic Neuropathy , 2007, Diabetes.

[17]  Hyman A. Carrel,et al.  Decreased density of corneal basal epithelium and subbasal corneal nerve bundle changes in patients with diabetic retinopathy. , 2006, American journal of ophthalmology.

[18]  J. V. van Best,et al.  Diabetes and Corneal Cell Densities in Humans by In Vivo Confocal Microscopy , 2006, Cornea.

[19]  M. Stewart,et al.  Diabetes Management in Canada: Baseline Results of the Group Practice Diabetes Management Study , 2006 .

[20]  P. Hossain,et al.  Early detection of diabetic peripheral neuropathy with corneal confocal microscopy , 2005, The Lancet.

[21]  Dan Ziegler,et al.  Diabetic neuropathies: a statement by the American Diabetes Association. , 2005, Diabetes care.

[22]  G. Gronseth,et al.  Distal symmetric polyneuropathy: A definition for clinical research , 2005, Neurology.

[23]  G. Rayman,et al.  The LDIflare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes. , 2004, Diabetes care.

[24]  L. Zinman,et al.  Cooling detection thresholds in the assessment of diabetic sensory polyneuropathy: comparison of CASE IV and Medoc instruments. , 2004, Diabetes care.

[25]  P. Sönksen,et al.  A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population , 1993, Diabetologia.

[26]  R. A. Malik,et al.  Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients , 2003, Diabetologia.

[27]  C. Sumner,et al.  The spectrum of neuropathy in diabetes and impaired glucose tolerance , 2003, Neurology.

[28]  B. Perkins,et al.  Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy. , 2002, Diabetes care.

[29]  J. Griffiths,et al.  The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[30]  D. Ziegler,et al.  Clinical trials for drugs against diabetic neuropathy: can we combine scientific needs with clinical practicalities? , 2002, International review of neurobiology.

[31]  N Efron,et al.  Morphology of Corneal Nerves Using Confocal Microscopy , 2001, Cornea.

[32]  B. Zinman,et al.  Simple screening tests for peripheral neuropathy in the diabetes clinic. , 2000, Diabetes care.

[33]  I. Immonen,et al.  Corneal structure and sensitivity in type 1 diabetes mellitus. , 2000, Investigative ophthalmology & visual science.

[34]  Clifford Goodman,et al.  American Academy of Physical Medicine and Rehabilitation , 1988 .

[35]  R. Beuerman,et al.  Density and organization of free nerve endings in the corneal epithelium of the rabbit , 1982, Pain.

[36]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[37]  R. Feldman,et al.  AMERICAN ACADEMY OF NEUROLOGY , 1949 .